You can review the latest news articles without logging in, but registration allows you to access all the information and have the choice of receiving an e-mail informing you of the latest updates to the site.
AHA 2008 Congress Coverage
InCirculation.net reported from the AHA Scientific Sessions 2008 in New Orleans. Our comprehensive coverage included news and exclusive interviews on JUPITER, I-PRESERVE, TIMACS, HF-ACTION and all the other major Late-Breakers. Our in-depth Congress Reports round up our coverage, keeping you abreast of all the talking points from the meeting.
 Audio Highlights
Click to listen or right-click to save as a podcast
JUPITER trial
In this exclusive interview with InCirculation.net editorial board member Roger Hall, Andrew Tonkin discusses the implications of the JUPITER trial, a landmark study demonstrating that rosuvastatin treatment significantly reduces the risk of cardiovascular disease morbidity and mortality in apparently healthy individuals.
TIMACSDeepak Bhatt reviews the TIMACS trial, a comparison of early and late interventional management in ACS patients. HF-ACTIONIgnore the purists, HF-ACTION findings on exercise in heart failure patients are “compelling” says Philip Poole-Wilson to InCirculation.net interviewer John McMurray. ATLAS ACS-TIMI 46Freek Verheugt reviews the promising results of ATLAS, a phase II trial evaluating the safety of rivaroxiban treatment in ACS patients. SEARCHDespite the spin, SEARCH was a “double-null outcome”, says Peter Wilson in this discussion with Sidney Goldstein. I-PRESERVEJohn Cleland gives his views on I-PRESERVE, a study of ARB treatment in a type of heart failure mostly affecting women and the elderly. JPADMarian Limacher addresses the results and wider implications of the JPAD trial, which assessed the use of aspirin to prevent atherosclerosis in diabetic patients. Latest Cardiovascular News |
What's New28 October 2008
Editorial: BEAUTIfUL: Ivabradine in heart failure
By: Sidney Goldstein The importance of the bradycardic effect of beta blockade in heart failure is now being tested with the development of drugs such as ivabradine that can slow the heart by inhibiting the If current in the sinoatrial node. Sidney Goldstein discusses the results of the BEAUTIfUL trial, which provides insight into the potential of these drugs in the treatment of patients with heart failure.
12 September 2008
Editorial: Chest compression-only for cardiac arrest?
By: Douglas Chamberlain The long-held norm for the resuscitation of cardiac arrest victims has involved both chest compressions and mouth-to-mouth ventilation. However, recent evidence has questioned whether compression-only resuscitation should be taught. Douglas Chamberlain, Honorary Professor of Resuscitation Medicine, Cardiff University, UK, reviews the arguments relevant to this controversy.28 August 2008
Editorial: Antihypertensive treatment: Is anybody old enough to make treatment useless?
By: Alberto Zanchetti The results of the HYVET trial on the benefits of blood pressure lowering in the very old hypertensive (aged 80 years or older) have recently been published. Alberto Zanchetti provides in-depth discussion of the importance of this trial for the management of hypertension. |
|
